BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22367914)

  • 1. The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors.
    Dani N; Olivero M; Mareschi K; van Duist MM; Miretti S; Cuvertino S; Patané S; Calogero R; Ferracini R; Scotlandi K; Fagioli F; Di Renzo MF
    J Bone Miner Res; 2012 Jun; 27(6):1322-34. PubMed ID: 22367914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-MYC overexpression with loss of Ink4a/Arf transforms bone marrow stromal cells into osteosarcoma accompanied by loss of adipogenesis.
    Shimizu T; Ishikawa T; Sugihara E; Kuninaka S; Miyamoto T; Mabuchi Y; Matsuzaki Y; Tsunoda T; Miya F; Morioka H; Nakayama R; Kobayashi E; Toyama Y; Kawai A; Ichikawa H; Hasegawa T; Okada S; Ito T; Ikeda Y; Suda T; Saya H
    Oncogene; 2010 Oct; 29(42):5687-99. PubMed ID: 20676132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness.
    Di Fiore R; Fanale D; Drago-Ferrante R; Chiaradonna F; Giuliano M; De Blasio A; Amodeo V; Corsini LR; Bazan V; Tesoriere G; Vento R; Russo A
    J Cell Physiol; 2013 Jun; 228(6):1189-201. PubMed ID: 23129384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteo-transcriptomics of human mesenchymal stem cells: accelerated gene expression and osteoblast differentiation induced by vitamin D reveals c-MYC as an enhancer of BMP2-induced osteogenesis.
    Piek E; Sleumer LS; van Someren EP; Heuver L; de Haan JR; de Grijs I; Gilissen C; Hendriks JM; van Ravestein-van Os RI; Bauerschmidt S; Dechering KJ; van Zoelen EJ
    Bone; 2010 Mar; 46(3):613-27. PubMed ID: 19857615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TSH-induced gene expression involves regulation of self-renewal and differentiation-related genes in human bone marrow-derived mesenchymal stem cells.
    Bagriacik EU; Yaman M; Haznedar R; Sucak G; Delibasi T
    J Endocrinol; 2012 Feb; 212(2):169-78. PubMed ID: 22128326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced differentiation of human embryonic stem cells to mesenchymal progenitors by inhibition of TGF-beta/activin/nodal signaling using SB-431542.
    Mahmood A; Harkness L; Schrøder HD; Abdallah BM; Kassem M
    J Bone Miner Res; 2010 Jun; 25(6):1216-33. PubMed ID: 20200949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New gene groups associated with dissimilar osteoblastic differentiation are linked to osteosarcomagenesis.
    Luk F; Yu Y; Dong HT; Walsh WR; Yang JL
    Cancer Genomics Proteomics; 2011; 8(2):65-75. PubMed ID: 21471516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of Osteosarcomas from a Combination of Rb Silencing and c-Myc Overexpression in Human Mesenchymal Stem Cells.
    Wang JY; Wu PK; Chen PC; Lee CW; Chen WM; Hung SC
    Stem Cells Transl Med; 2017 Feb; 6(2):512-526. PubMed ID: 28191765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteosarcoma and osteoblastic differentiation: a new perspective on oncogenesis.
    Haydon RC; Luu HH; He TC
    Clin Orthop Relat Res; 2007 Jan; 454():237-46. PubMed ID: 17075380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation.
    Kulterer B; Friedl G; Jandrositz A; Sanchez-Cabo F; Prokesch A; Paar C; Scheideler M; Windhager R; Preisegger KH; Trajanoski Z
    BMC Genomics; 2007 Mar; 8():70. PubMed ID: 17352823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling human osteosarcoma in mice through 3AB-OS cancer stem cell xenografts.
    Di Fiore R; Guercio A; Puleio R; Di Marco P; Drago-Ferrante R; D'Anneo A; De Blasio A; Carlisi D; Di Bella S; Pentimalli F; Forte IM; Giordano A; Tesoriere G; Vento R
    J Cell Biochem; 2012 Nov; 113(11):3380-92. PubMed ID: 22688921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MET oncogene is a functional marker of a glioblastoma stem cell subtype.
    De Bacco F; Casanova E; Medico E; Pellegatta S; Orzan F; Albano R; Luraghi P; Reato G; D'Ambrosio A; Porrati P; Patanè M; Maderna E; Pollo B; Comoglio PM; Finocchiaro G; Boccaccio C
    Cancer Res; 2012 Sep; 72(17):4537-50. PubMed ID: 22738909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2.
    Mohseny AB; Szuhai K; Romeo S; Buddingh EP; Briaire-de Bruijn I; de Jong D; van Pel M; Cleton-Jansen AM; Hogendoorn PC
    J Pathol; 2009 Nov; 219(3):294-305. PubMed ID: 19718709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of human skeletal stem cells differentiation by Dlk1/Pref-1.
    Abdallah BM; Jensen CH; Gutierrez G; Leslie RG; Jensen TG; Kassem M
    J Bone Miner Res; 2004 May; 19(5):841-52. PubMed ID: 15068508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human osteoblasts derived from mesenchymal stem cells express adipogenic markers upon coculture with bone marrow adipocytes.
    Clabaut A; Delplace S; Chauveau C; Hardouin P; Broux O
    Differentiation; 2010 Jul; 80(1):40-5. PubMed ID: 20466479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells derived from human exocrine pancreas express transcription factors implicated in beta-cell development.
    Baertschiger RM; Bosco D; Morel P; Serre-Beinier V; Berney T; Buhler LH; Gonelle-Gispert C
    Pancreas; 2008 Jul; 37(1):75-84. PubMed ID: 18580448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells.
    Nöth U; Osyczka AM; Tuli R; Hickok NJ; Danielson KG; Tuan RS
    J Orthop Res; 2002 Sep; 20(5):1060-9. PubMed ID: 12382974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel markers of mesenchymal stem cells defined by genome-wide gene expression analysis of stromal cells from different sources.
    Kaltz N; Ringe J; Holzwarth C; Charbord P; Niemeyer M; Jacobs VR; Peschel C; Häupl T; Oostendorp RA
    Exp Cell Res; 2010 Oct; 316(16):2609-17. PubMed ID: 20599957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic modifications in osteogenic differentiation and transformation.
    Thomas D; Kansara M
    J Cell Biochem; 2006 Jul; 98(4):757-69. PubMed ID: 16598744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling.
    Cantiani L; Manara MC; Zucchini C; De Sanctis P; Zuntini M; Valvassori L; Serra M; Olivero M; Di Renzo MF; Colombo MP; Picci P; Scotlandi K
    Cancer Res; 2007 Aug; 67(16):7675-85. PubMed ID: 17699771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.